Cyclerion Therapeutics Stock (NASDAQ: CYCN) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 3.92K |
Day Range | - - - |
52 Wk Range | 1.75 - 5.25 |
Market Cap | $5.77M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 0.88% |
Days to Cover | 7.06 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cyclerion Therapeutics (NASDAQ:CYCN) through any online brokerage.
Other companies in Cyclerion Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Virios Therapeutics (NASDAQ:VIRI), Synaptogenix (NASDAQ:SNPX), NuCana (NASDAQ:NCNA) and Genprex (NASDAQ:GNPX).
There is no analysis for Cyclerion Therapeutics.
Cyclerion Therapeutics has a consensus price target of $10.50.
The stock price for Cyclerion Therapeutics (NASDAQ: CYCN) is $2.325 last updated July 2, 2024 at 12:23 PM EDT.
There are no upcoming dividends for Cyclerion Therapeutics.
Cyclerion Therapeutics’s Q2 earnings are confirmed for Friday, July 26, 2024.
There is no upcoming split for Cyclerion Therapeutics.
Cyclerion Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.